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Tracking perioperative mortality and maternal mortality: 
challenges and opportunities
Access to surgery remains inequitable worldwide, 
with 5 billion people lacking safe and aﬀ ordable 
surgical and anaesthesia care when needed.1 The Lancet 
Commission on Global Surgery was convened in 2013 
to assess the state of surgery around the world, provide 
recommendations for improving access, and propose 
indicators for assessing national surgical systems. 
A key safety indicator is the perioperative mortality 
rate (POMR). This is deﬁ ned by the Commission as the 
number of all-cause deaths before discharge in patients 
who have undergone a procedure in an operating 
theatre, divided by the total number of procedures, and 
presented as a percentage.1 While the surgical literature 
is replete with mortality data at a health facility level, 
the collection of nationally representative data is more 
challenging and is less frequently reported.2 However, 
recent work has shown that many countries already 
collect national data on deaths after surgery, including 
several middle-income countries.3 Whereas POMR is 
just emerging, the maternal mortality ratio (MMR) is an 
established population health indicator. Both are ratio 
indicators with numerators and denominators that are 
commonly recorded, making them seemingly straight-
forward to monitor. Yet MMR has faced numerous 
challenges through its evolution, creating a cautionary 
tale and revealing what is needed for POMR to succeed.
In particular, problems with MMR have included 
under reported and misclassiﬁ ed maternal deaths, 
unreliable civil registration systems, use of diﬀ erent 
data sources in various settings over time, and changes 
in deﬁ nition of maternal mortality.4,5 Broadly, the 
challenges in measuring MMR have been categorised as 
the deﬁ nitional challenge and the challenge of ﬁ nding 
deaths.6 Variable data availability and reporting errors 
have made medical cause and time of death diﬃ  cult to 
establish, especially in regions where most deaths occur 
outside of hospital due to women’s lack of access to 
care. Methodological concerns have resulted in at least 
18 empirical measurement tools to use depending on 
country and facility context.6
Despite the challenges, since the Safe Motherhood 
Initiative was launched almost 30 years ago, international 
institutions such as the World Bank and WHO, and 
independent groups such as the Institute for Health 
Metrics and Evaluation, have developed, published, and 
continually reﬁ ned estimates of maternal mortality. 
Indirect and sampled methods of estimation for MMR 
such as verbal autopsy studies, the sisterhood method, 
and the reproductive age mortality survey (RAMOS) 
as well as systematic analyses of vital registration data 
undertaken by the Global Burden of Disease study have 
all contributed to improvements in our understanding 
of maternal mortality.4,7 Maternal death reporting 
has evolved into an essential country-level indicator, 
providing critical evidence for policy formulation, priority 
setting, monitoring and evaluation, and accountability.7,8
Policymakers using POMR can draw on lessons from the 
MMR. First, POMR requires a clear and standard deﬁ nition 
that is feasible to measure.9 In-hospital deaths are more 
feasible to count than the often-used deﬁ nition of deaths 
within 30 days following a procedure, as post-discharge 
records may not be available.9 Yet POMR faces a unique 
deﬁ nitional challenge: the types of procedures present 
in the denominator will vary with context, and thus for 
robust comparative analysis, a clear accounting of the 
types of procedures performed must be made.
Second, reliable and accessible data sources must 
be identiﬁ ed and harnessed. Research has shown that 
low-cost, locally developed, facility-based databases 
in low-income and middle-income countries can 
provide accurate death statistics.10 The denominator of 
POMR is purely clinical (surgical procedure) rather than 
natural (pregnancy) and so facility-based records are 
suﬃ  cient for its calculation. For both POMR and MMR, 
institutional resistance to provide accurate but potentially 
self-damaging information may be a signiﬁ cant challenge; 
governments and regulatory bodies must be clear that 
they intend to use POMR to identify problems and 
allocate resources accordingly rather than for castigating 
the conscientious surgeons and institutions who care for 
the sickest patients with the highest POMR.
It is important for all countries to have a common 
baseline for data: this is the POMR deﬁ nition supported 
by the Commission and others.9,11 However, beyond 
the collection of this datum, the evidence does not 
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in mortality and use this information to improve 
surgical safety. As with MMR, case studies may be 
used to illustrate successful approaches towards data 
collection and outcome improve ment.12 Countries can 
propose feasible data collection systems to evaluate 
surgical deaths. The WHO and other UN organisations, 
academic institutions, and other technical partners can 
in turn provide guidelines and methodological support 
for governments wishing to engage in such analysis. 
In the early stages, aggregate POMR may be used to 
provide crude information on system performance in 
facilities where case mix information is not provided. 
Over time, a standardised approach to reporting and risk 
stratiﬁ cation can be adopted to allow for comparison of 
outcomes between countries and regions over time. 
With surgery gaining acceptance as an essential and 
cost-eﬀ ective public health measure across all levels of 
economic development, there is increasing interest in 
interventions to improve surgical outcomes. Without a 
clear strategy for measuring nationally representative 
perioperative mortality rates, governments cannot 
assess how invest ments in health systems aﬀ ect the 
safety of surgical care provided. Learning from history in 
related ﬁ elds can help ease the growing pains of POMR 
as a new health indicator. 
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